Bone Biologics Corp Warrants
BBLGW
3 hedge funds and large institutions have $570K invested in Bone Biologics Corp Warrants in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
1,170% more capital invested
Capital invested by funds: $44.9K → $570K (+$525K)
200% more funds holding
Funds holding: 1 → 3 (+2)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
5.9% more ownership
Funds ownership: 0.37% → 6.27% (+5.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$364K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$1.1K |
| 3 |
CS
Clear Street
New York
|
+$1.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MG
Marex Group
London,
|
-$44.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $568K | +$364K | +33,037 | New |
|
|
CS
2
Clear Street
New York
| $1.72K | +$1.1K | +100 | New |
|
|
3
Bank of America
Charlotte,
North Carolina
| $414 | +$1.1K | +100 | New |
|
|
MG
4
Marex Group
London,
| – | -$44.9K | -11,460 | Closed |
|
BBLGW Hedge Fund Activity: Q1 2024 in Review
3 of the 6,945 institutional investors tracked by Wall St. Rank reported a position in Bone Biologics Corp Warrants (BBLGW) for Q1 2024, worth a combined $570K — up 1,170% from $44.9K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BBLGW positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $364K. The largest seller was Marex Group, exiting entirely with an estimated $44.9K sold.
- 3 institutional investors held Bone Biologics Corp Warrants (BBLGW) as of Q1 2024, up from 1 in Q4 2023.
- Funds reported $570K of Bone Biologics Corp Warrants stock for Q1 2024, up 1,170% quarter-over-quarter.
- 3 funds opened new Bone Biologics Corp Warrants positions in Q1 2024 and 1 closed out, a net change of +2 holders.
- The largest Bone Biologics Corp Warrants buyer in Q1 2024 was Citadel Advisors, an estimated $364K added.
- The largest Bone Biologics Corp Warrants seller in Q1 2024 was Marex Group, an estimated $44.9K sold.
Based on aggregated 13F filings for Q1 2024.